Actinium

未知生产厂商

Actinium has been investigated for the treatment of Breast Cancer and Pulmonary Disease, Chronic Obstructive.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Actinium has been investigated for the treatment of Breast Cancer and Pulmonary Disease, Chronic Obstructive.

技术标识符

化学式: Ac
CAS 编号: 7440-34-8
UNII ID: NIK1K0956U

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

METHOD FOR TREATING CANCER USING A BCL-2 INHIBITOR IN CONJUNCTION WITH AN ALPHA-EMITTING RADIOIMMUNOTHERAPEUTIC
EP 3615047 A4申请人: ACTINIUM PHARMACEUTICALS INC优先权: 2017
CN
EP
US
WO
12 件公开
STABILIZED RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN COMPOSITIONS
EP 3426305 B1申请人: ACTINIUM PHARMACEUTICALS INC优先权: 2016
EP
US
WO
11 件公开
METHOD FOR PURIFICATION OF 225AC FROM IRRADIATED 226RA-TARGETS
US 2009191122 A1申请人: ACTINIUM PHARMACEUTICALS INC优先权: 2006
CN
EP
US
WO
9 件公开
MACROCYCLIC CHELATORS AND METHODS OF USE THEREOF
EP 3966211 C0申请人: JANSSEN BIOTECH INC优先权: 2019
CN
EP
US
WO
7 件公开
LOW DOSE ANTIBODY-BASED METHODS FOR TREATING HEMATOLOGIC MALIGNANCIES
EP 3464363 A1申请人: ACTINIUM PHARMACEUTICALS INC优先权: 2016
EP
US
WO
7 件公开
BIFUNCTIONAL CHELATORS AND CONJUGATES
EP 4536278 A4申请人: ACTINIUM PHARMACEUTICALS INC优先权: 2022
EP
US
WO
7 件公开
HUMANIZED ANTI-CD45 ANTIBODIES
EP 4490197 A4申请人: ACTINIUM PHARMACEUTICALS INC优先权: 2022
CN
EP
US
WO
6 件公开
Inorganic colors and related nanotechnology
US 2008156228 A1申请人: NANOPRODUCTS CORP优先权: 2003
US
6 件公开
RADIOLABELING OF ANTI-CD45 IMMUNOGLOBULIN AND METHODS OF USE THEREOF
EP 4031188 A4申请人: ACTINIUM PHARMACEUTICALS INC优先权: 2019
CN
EP
US
WO
5 件公开
Method for producing Ac-225 solution and method for producing medicine using Ac-225 solution
US 11752223 B2申请人: NIHON MEDIPHYSICS CO LTD优先权: 2021
EP
US
WO
5 件公开

药物